Phase 2/3 Outsourced Spend Across Provider Types
By Rebecca McAvoy, VP of Market Research, Industry Standard Research
Overall, half of Phase 2/3 outsourcing spend goes to large, full-service CROs (51%) while one-quarter of spend (26%) goes to midsize, multi-service CROs. Small or niche service CROs and academic medical centers (AMCs) receive the remaining 14% and 9% of spend, respectively.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.